Neuralstem, Inc. News Headlines

CUR 
$2.55
*  
0.15
5.56%
Get CUR Alerts
*Delayed - data as of Dec. 18, 2014 10:10 ET  -  Find a broker to begin trading CUR now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    CUR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
2 Biotech Stocks Announcing Key Early Stage Clinical Developments
4/17/2013 2:22:00 PM - Seeking Alpha


Investing In The Stem Cell Sector: An Overview
4/17/2013 8:36:00 AM - Seeking Alpha


The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
4/10/2013 4:00:00 AM - Seeking Alpha


Updating A Speculative Idea And Sharing A New One
4/1/2013 12:36:00 PM - Seeking Alpha


Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy
3/28/2013 9:14:00 AM - Seeking Alpha


Buy Hercules Tech Growth Capital Instead Of OCZ Tech
3/27/2013 6:35:00 AM - Seeking Alpha


The Future Of Medicine: A Look At 5 Stem Cell Companies
3/22/2013 11:58:00 AM - Seeking Alpha


Neuralstem Update Fails To Excite, All Eyes On Upcoming Phase II Trial
3/21/2013 12:23:00 PM - Seeking Alpha


Neuralstem: A Top Regenerative Medicine Play
3/18/2013 11:03:00 AM - Seeking Alpha


ALS Crisis Of Conscience At FDA Spells Opportunity For Neuralstem, Brainstorm
3/7/2013 8:20:00 AM - Seeking Alpha


After Successful ALS Phase I, Neuralstem Branches Out
3/5/2013 5:42:00 AM - Seeking Alpha


Regenerative Medicine: Some Realism Please
2/22/2013 11:06:00 AM - Seeking Alpha


Athersys: The Coming Year Will Define MultiStem, Its Adult Stem Cell Product
2/8/2013 12:03:00 PM - Seeking Alpha


3 Regenerative Medicine Companies That Could Deliver In 2013
1/22/2013 9:33:00 AM - Seeking Alpha


Stem Cell Stocks To Consider: Aastrom, Athersys, StemCells And Neuralstem
1/16/2013 2:35:00 PM - Seeking Alpha


The Race To Cure Spinal Cord Injuries
1/15/2013 12:45:00 PM - Seeking Alpha


Stem Cell Companies For Consideration In 2013
1/9/2013 6:35:00 AM - Seeking Alpha


2012 Breakthroughs In Cell Therapy Development
1/7/2013 9:13:00 AM - Seeking Alpha


Weak Trading In Athersys Following Share Dilution
1/6/2013 4:46:00 PM - Seeking Alpha


6 Micro Caps To Add To Your Portfolio For 2013
12/27/2012 6:07:00 AM - Seeking Alpha


Neuralstem Shows ALS Can Be Beaten Back - Now On To Phase II
12/19/2012 2:43:00 PM - Seeking Alpha


Pershing Gold: Not A Daytrade But A Long-Term Investment
12/18/2012 2:42:00 PM - Seeking Alpha


Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learned
12/16/2012 8:42:00 AM - Seeking Alpha


Biotech Weekly Recap: The Market Holds While Biotech Crumbles
12/9/2012 10:16:00 PM - Seeking Alpha


Maxim Group Highlights 3 Stem Cells Stocks To Consider And 1 To Avoid
12/4/2012 10:03:00 AM - Seeking Alpha